Melanie Cree
Concepts (392)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polycystic Ovary Syndrome | 25 | 2024 | 163 | 12.990 |
Why?
| Insulin Resistance | 59 | 2024 | 1164 | 10.710 |
Why?
| Diabetes Mellitus, Type 2 | 31 | 2023 | 2428 | 4.090 |
Why?
| Mitochondria, Muscle | 11 | 2024 | 110 | 3.770 |
Why?
| Obesity | 29 | 2024 | 2859 | 3.650 |
Why?
| Blood Glucose | 37 | 2023 | 2092 | 3.350 |
Why?
| Pediatric Obesity | 11 | 2025 | 570 | 2.920 |
Why?
| Glucose Intolerance | 11 | 2021 | 142 | 2.900 |
Why?
| Glucose Clamp Technique | 16 | 2023 | 194 | 2.650 |
Why?
| Muscle, Skeletal | 30 | 2024 | 1620 | 2.540 |
Why?
| Insulin | 27 | 2024 | 2316 | 2.360 |
Why?
| Metformin | 10 | 2021 | 312 | 2.340 |
Why?
| Adolescent | 77 | 2025 | 20158 | 2.270 |
Why?
| Glucose Tolerance Test | 20 | 2023 | 356 | 2.260 |
Why?
| Testosterone | 7 | 2024 | 369 | 2.240 |
Why?
| Fasting | 7 | 2024 | 264 | 2.090 |
Why?
| Liver | 12 | 2023 | 1826 | 2.080 |
Why?
| Fatty Liver | 5 | 2024 | 231 | 2.070 |
Why?
| Hyperandrogenism | 3 | 2024 | 18 | 1.950 |
Why?
| Triglycerides | 9 | 2022 | 523 | 1.950 |
Why?
| Fatty Acids, Nonesterified | 7 | 2018 | 159 | 1.640 |
Why?
| Diabetes Mellitus, Type 1 | 17 | 2024 | 3625 | 1.620 |
Why?
| Metabolic Syndrome | 3 | 2020 | 338 | 1.590 |
Why?
| Burns | 9 | 2010 | 284 | 1.480 |
Why?
| Female | 96 | 2025 | 68017 | 1.460 |
Why?
| Lipid Metabolism | 6 | 2019 | 491 | 1.400 |
Why?
| Lipolysis | 4 | 2019 | 40 | 1.390 |
Why?
| Body Mass Index | 11 | 2024 | 2260 | 1.340 |
Why?
| Hyperinsulinism | 4 | 2019 | 119 | 1.330 |
Why?
| Young Adult | 36 | 2025 | 12282 | 1.280 |
Why?
| Child | 49 | 2024 | 20636 | 1.250 |
Why?
| Adipose Tissue | 6 | 2022 | 589 | 1.240 |
Why?
| Magnetic Resonance Spectroscopy | 9 | 2024 | 510 | 1.210 |
Why?
| Cross-Sectional Studies | 22 | 2024 | 5034 | 1.210 |
Why?
| Circadian Rhythm | 6 | 2025 | 409 | 1.170 |
Why?
| Humans | 117 | 2025 | 128020 | 1.170 |
Why?
| Glycerol | 6 | 2023 | 87 | 1.160 |
Why?
| Oxidative Phosphorylation | 4 | 2019 | 184 | 1.150 |
Why?
| Hypoglycemic Agents | 9 | 2019 | 1212 | 1.050 |
Why?
| Glucose | 10 | 2023 | 983 | 1.030 |
Why?
| Body Composition | 6 | 2024 | 644 | 0.960 |
Why?
| Insulin-Secreting Cells | 6 | 2020 | 367 | 0.950 |
Why?
| Case-Control Studies | 15 | 2024 | 3324 | 0.950 |
Why?
| Exercise | 12 | 2024 | 1917 | 0.920 |
Why?
| Male | 70 | 2025 | 62758 | 0.880 |
Why?
| Cardiovascular Diseases | 6 | 2019 | 1994 | 0.880 |
Why?
| Androgens | 2 | 2022 | 173 | 0.850 |
Why?
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 146 | 0.830 |
Why?
| Prediabetic State | 4 | 2021 | 245 | 0.830 |
Why?
| Gastrointestinal Microbiome | 2 | 2021 | 631 | 0.820 |
Why?
| Transition to Adult Care | 1 | 2024 | 76 | 0.800 |
Why?
| Hyperglycemia | 4 | 2021 | 326 | 0.790 |
Why?
| Non-alcoholic Fatty Liver Disease | 3 | 2021 | 258 | 0.770 |
Why?
| Adult | 43 | 2024 | 35177 | 0.760 |
Why?
| Adenosine Diphosphate | 2 | 2021 | 78 | 0.730 |
Why?
| Klinefelter Syndrome | 1 | 2021 | 56 | 0.700 |
Why?
| Overweight | 6 | 2025 | 522 | 0.690 |
Why?
| Obesity, Morbid | 1 | 2024 | 239 | 0.690 |
Why?
| Desogestrel | 1 | 2020 | 46 | 0.680 |
Why?
| Adolescent Medicine | 1 | 2020 | 36 | 0.680 |
Why?
| Lipogenesis | 2 | 2019 | 59 | 0.670 |
Why?
| Isotopes | 1 | 2019 | 28 | 0.660 |
Why?
| Inservice Training | 1 | 2020 | 111 | 0.650 |
Why?
| Endocrinology | 1 | 2020 | 74 | 0.640 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 37 | 0.630 |
Why?
| Energy Metabolism | 3 | 2024 | 831 | 0.620 |
Why?
| Gluconeogenesis | 1 | 2019 | 73 | 0.620 |
Why?
| Absorptiometry, Photon | 6 | 2024 | 248 | 0.620 |
Why?
| Obesity, Abdominal | 1 | 2018 | 47 | 0.600 |
Why?
| Mentors | 1 | 2020 | 178 | 0.600 |
Why?
| Sleep | 4 | 2025 | 675 | 0.580 |
Why?
| Gynecology | 1 | 2020 | 175 | 0.580 |
Why?
| Interprofessional Relations | 1 | 2020 | 270 | 0.570 |
Why?
| Mentoring | 1 | 2020 | 130 | 0.570 |
Why?
| Adiposity | 4 | 2018 | 504 | 0.560 |
Why?
| Fatty Acids | 2 | 2019 | 415 | 0.560 |
Why?
| Fenofibrate | 2 | 2007 | 31 | 0.550 |
Why?
| Depressive Disorder | 1 | 2020 | 354 | 0.540 |
Why?
| Amino Acids | 3 | 2019 | 476 | 0.540 |
Why?
| Lipoproteins, HDL | 1 | 2017 | 85 | 0.540 |
Why?
| Biodiversity | 1 | 2020 | 373 | 0.530 |
Why?
| Hypolipidemic Agents | 2 | 2007 | 92 | 0.530 |
Why?
| C-Peptide | 5 | 2019 | 163 | 0.520 |
Why?
| Oxygen Consumption | 9 | 2024 | 669 | 0.520 |
Why?
| Mitochondria | 5 | 2024 | 847 | 0.470 |
Why?
| Muscle Proteins | 7 | 2017 | 221 | 0.470 |
Why?
| Severity of Illness Index | 4 | 2025 | 2703 | 0.460 |
Why?
| Aging | 3 | 2019 | 1745 | 0.460 |
Why?
| Sleep Apnea, Obstructive | 2 | 2025 | 238 | 0.450 |
Why?
| Prognosis | 5 | 2020 | 3766 | 0.450 |
Why?
| Lipoproteins | 1 | 2015 | 171 | 0.450 |
Why?
| Diabetes Mellitus | 2 | 2020 | 994 | 0.450 |
Why?
| B-Lymphocytes | 1 | 2019 | 812 | 0.440 |
Why?
| Bacteria | 1 | 2020 | 812 | 0.430 |
Why?
| Decision Making | 1 | 2020 | 846 | 0.420 |
Why?
| Oxygen | 1 | 2018 | 899 | 0.420 |
Why?
| PPAR alpha | 3 | 2007 | 59 | 0.420 |
Why?
| Magnetic Resonance Imaging | 6 | 2024 | 3371 | 0.410 |
Why?
| Cardiorespiratory Fitness | 3 | 2024 | 48 | 0.410 |
Why?
| Follow-Up Studies | 6 | 2020 | 4853 | 0.400 |
Why?
| Bed Rest | 2 | 2009 | 14 | 0.400 |
Why?
| Cohort Studies | 8 | 2021 | 5378 | 0.400 |
Why?
| Risk Factors | 11 | 2021 | 9696 | 0.390 |
Why?
| Calorimetry, Indirect | 2 | 2024 | 80 | 0.380 |
Why?
| Insulin Glargine | 3 | 2019 | 80 | 0.370 |
Why?
| Puberty | 3 | 2024 | 142 | 0.360 |
Why?
| Cystic Fibrosis | 1 | 2020 | 1048 | 0.350 |
Why?
| Hirsutism | 2 | 2021 | 12 | 0.340 |
Why?
| Cushing Syndrome | 1 | 2009 | 10 | 0.330 |
Why?
| Gastroplasty | 2 | 2021 | 29 | 0.330 |
Why?
| Algorithms | 2 | 2021 | 1609 | 0.320 |
Why?
| Diabetic Nephropathies | 3 | 2020 | 278 | 0.320 |
Why?
| Estradiol | 3 | 2022 | 486 | 0.320 |
Why?
| Prospective Studies | 7 | 2020 | 7035 | 0.320 |
Why?
| Retrospective Studies | 8 | 2024 | 14404 | 0.310 |
Why?
| Middle Aged | 15 | 2024 | 30813 | 0.310 |
Why?
| Sex Characteristics | 3 | 2025 | 719 | 0.280 |
Why?
| Protein Kinase C | 1 | 2008 | 255 | 0.270 |
Why?
| Exercise Tolerance | 4 | 2017 | 271 | 0.270 |
Why?
| Autoimmunity | 1 | 2012 | 860 | 0.250 |
Why?
| Diabetic Cardiomyopathies | 2 | 2016 | 34 | 0.250 |
Why?
| Actigraphy | 3 | 2025 | 94 | 0.250 |
Why?
| Melatonin | 3 | 2025 | 120 | 0.240 |
Why?
| Reproducibility of Results | 8 | 2025 | 3009 | 0.240 |
Why?
| Biological Clocks | 1 | 2025 | 40 | 0.230 |
Why?
| Carnitine | 3 | 2019 | 76 | 0.230 |
Why?
| Adiponectin | 2 | 2016 | 234 | 0.230 |
Why?
| Lipoproteins, VLDL | 1 | 2024 | 22 | 0.230 |
Why?
| Polysomnography | 1 | 2025 | 160 | 0.220 |
Why?
| Alanine Transaminase | 1 | 2024 | 151 | 0.220 |
Why?
| Basal Metabolism | 1 | 2024 | 57 | 0.220 |
Why?
| Adenosine Triphosphate | 2 | 2021 | 469 | 0.220 |
Why?
| Age Factors | 3 | 2020 | 3100 | 0.220 |
Why?
| Lipids | 4 | 2017 | 619 | 0.220 |
Why?
| Leg | 5 | 2021 | 236 | 0.210 |
Why?
| Muscle Contraction | 3 | 2014 | 423 | 0.210 |
Why?
| Aged | 11 | 2020 | 21892 | 0.210 |
Why?
| Endocrine System Diseases | 1 | 2023 | 33 | 0.210 |
Why?
| Continuity of Patient Care | 1 | 2006 | 275 | 0.210 |
Why?
| Gonadotropin-Releasing Hormone | 1 | 2024 | 207 | 0.210 |
Why?
| Time Factors | 6 | 2025 | 6479 | 0.200 |
Why?
| Colorado | 5 | 2020 | 4369 | 0.200 |
Why?
| Muscle Strength | 2 | 2017 | 304 | 0.200 |
Why?
| Vascular Stiffness | 2 | 2019 | 463 | 0.200 |
Why?
| Sleep Deprivation | 1 | 2025 | 171 | 0.200 |
Why?
| Saliva | 2 | 2025 | 207 | 0.200 |
Why?
| Child, Preschool | 9 | 2022 | 10378 | 0.200 |
Why?
| Carbon Isotopes | 4 | 2019 | 123 | 0.200 |
Why?
| Hospitalization | 2 | 2016 | 2057 | 0.190 |
Why?
| Tandem Mass Spectrometry | 1 | 2024 | 452 | 0.190 |
Why?
| Double-Blind Method | 3 | 2019 | 1852 | 0.190 |
Why?
| Sex Factors | 3 | 2017 | 1942 | 0.190 |
Why?
| Biomarkers | 6 | 2019 | 3874 | 0.190 |
Why?
| Sleep Wake Disorders | 2 | 2019 | 248 | 0.190 |
Why?
| Phosphocreatine | 1 | 2021 | 40 | 0.190 |
Why?
| Transgender Persons | 1 | 2024 | 171 | 0.180 |
Why?
| Glutathione | 1 | 2023 | 340 | 0.180 |
Why?
| Alopecia | 1 | 2021 | 28 | 0.180 |
Why?
| Bacteroidetes | 1 | 2021 | 23 | 0.180 |
Why?
| Firmicutes | 1 | 2021 | 18 | 0.180 |
Why?
| Body Weight | 2 | 2019 | 930 | 0.180 |
Why?
| Contraceptive Devices, Female | 1 | 2020 | 10 | 0.180 |
Why?
| Protein Biosynthesis | 2 | 2017 | 397 | 0.180 |
Why?
| Ovarian Reserve | 1 | 2020 | 13 | 0.170 |
Why?
| Sex Chromosome Disorders of Sex Development | 1 | 2020 | 15 | 0.170 |
Why?
| Drug Implants | 1 | 2020 | 83 | 0.170 |
Why?
| Primary Ovarian Insufficiency | 1 | 2020 | 34 | 0.170 |
Why?
| Carotid Intima-Media Thickness | 2 | 2018 | 90 | 0.170 |
Why?
| Glucose Metabolism Disorders | 1 | 2019 | 11 | 0.160 |
Why?
| Prednisolone | 1 | 2019 | 82 | 0.160 |
Why?
| Physicians, Women | 1 | 2020 | 70 | 0.160 |
Why?
| Aorta | 2 | 2019 | 408 | 0.160 |
Why?
| United States | 3 | 2021 | 13785 | 0.160 |
Why?
| Device Removal | 1 | 2020 | 134 | 0.160 |
Why?
| Arginine | 2 | 2019 | 259 | 0.160 |
Why?
| Liraglutide | 1 | 2019 | 29 | 0.160 |
Why?
| Sitagliptin Phosphate | 1 | 2019 | 31 | 0.160 |
Why?
| Amino Acids, Essential | 2 | 2009 | 13 | 0.160 |
Why?
| Uromodulin | 1 | 2019 | 21 | 0.160 |
Why?
| Adrenocorticotropic Hormone | 1 | 2019 | 133 | 0.160 |
Why?
| Virilism | 1 | 2019 | 5 | 0.160 |
Why?
| Menstruation Disturbances | 1 | 2019 | 12 | 0.160 |
Why?
| Waist Circumference | 1 | 2019 | 138 | 0.160 |
Why?
| Sex Hormone-Binding Globulin | 1 | 2019 | 53 | 0.160 |
Why?
| Withholding Treatment | 1 | 2019 | 70 | 0.150 |
Why?
| Diastole | 1 | 2019 | 148 | 0.150 |
Why?
| Predictive Value of Tests | 1 | 2024 | 1934 | 0.150 |
Why?
| Spironolactone | 1 | 2019 | 28 | 0.150 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 45 | 0.150 |
Why?
| Contraceptives, Oral | 1 | 2019 | 39 | 0.150 |
Why?
| Respiratory Function Tests | 1 | 2020 | 580 | 0.150 |
Why?
| Deuterium | 3 | 2015 | 86 | 0.150 |
Why?
| RNA, Ribosomal, 16S | 1 | 2021 | 519 | 0.150 |
Why?
| Wakefulness | 1 | 2019 | 120 | 0.150 |
Why?
| Peer Group | 1 | 2020 | 224 | 0.150 |
Why?
| Minority Groups | 1 | 2020 | 250 | 0.150 |
Why?
| Career Choice | 1 | 2020 | 207 | 0.150 |
Why?
| Intra-Abdominal Fat | 1 | 2018 | 88 | 0.150 |
Why?
| Cardiotonic Agents | 1 | 2018 | 124 | 0.150 |
Why?
| Cell Respiration | 1 | 2018 | 98 | 0.150 |
Why?
| Psychiatric Status Rating Scales | 1 | 2020 | 520 | 0.150 |
Why?
| Erythrocytes | 1 | 2023 | 673 | 0.140 |
Why?
| Feces | 1 | 2021 | 435 | 0.140 |
Why?
| Spasms, Infantile | 1 | 2019 | 121 | 0.140 |
Why?
| Universities | 1 | 2020 | 399 | 0.140 |
Why?
| Social Media | 1 | 2020 | 137 | 0.140 |
Why?
| Phosphorus Isotopes | 1 | 2017 | 7 | 0.140 |
Why?
| Kidney | 4 | 2021 | 1306 | 0.140 |
Why?
| Incidence | 2 | 2021 | 2614 | 0.140 |
Why?
| Blood Vessels | 1 | 2018 | 181 | 0.140 |
Why?
| Hindlimb | 1 | 2017 | 125 | 0.140 |
Why?
| Child Behavior | 1 | 2019 | 235 | 0.140 |
Why?
| Occupational Exposure | 1 | 2020 | 299 | 0.130 |
Why?
| Affect | 1 | 2019 | 284 | 0.130 |
Why?
| Human Development | 1 | 2016 | 16 | 0.130 |
Why?
| Placental Insufficiency | 1 | 2017 | 111 | 0.130 |
Why?
| Prevalence | 2 | 2021 | 2541 | 0.130 |
Why?
| Societies, Medical | 1 | 2020 | 741 | 0.130 |
Why?
| Hospitals, Pediatric | 2 | 2017 | 505 | 0.130 |
Why?
| Regional Blood Flow | 2 | 2016 | 457 | 0.130 |
Why?
| Social Support | 1 | 2020 | 588 | 0.130 |
Why?
| Parenting | 1 | 2020 | 296 | 0.130 |
Why?
| Bone Density | 1 | 2020 | 474 | 0.130 |
Why?
| Estrogens | 1 | 2019 | 342 | 0.130 |
Why?
| Metabolome | 1 | 2019 | 319 | 0.120 |
Why?
| Milk Proteins | 2 | 2006 | 33 | 0.120 |
Why?
| Leptin | 1 | 2017 | 218 | 0.120 |
Why?
| Pneumonia, Viral | 1 | 2020 | 337 | 0.120 |
Why?
| Coronavirus Infections | 1 | 2020 | 333 | 0.120 |
Why?
| Drug Therapy, Combination | 1 | 2018 | 1012 | 0.120 |
Why?
| Glucocorticoids | 1 | 2019 | 572 | 0.120 |
Why?
| Schools | 1 | 2018 | 436 | 0.120 |
Why?
| Life Style | 2 | 2018 | 459 | 0.120 |
Why?
| Emergency Service, Hospital | 1 | 2006 | 1896 | 0.120 |
Why?
| Pulse Wave Analysis | 3 | 2021 | 246 | 0.110 |
Why?
| Phosphorus | 1 | 2014 | 93 | 0.110 |
Why?
| Biopsy | 2 | 2008 | 1077 | 0.110 |
Why?
| Metabolomics | 1 | 2019 | 599 | 0.110 |
Why?
| Exercise Therapy | 1 | 2018 | 412 | 0.110 |
Why?
| Inflammation Mediators | 1 | 2017 | 495 | 0.110 |
Why?
| Glomerular Filtration Rate | 4 | 2020 | 682 | 0.110 |
Why?
| Surveys and Questionnaires | 2 | 2020 | 5353 | 0.100 |
Why?
| Echocardiography | 1 | 2016 | 623 | 0.100 |
Why?
| Risk Assessment | 2 | 2017 | 3223 | 0.100 |
Why?
| Blood Pressure | 2 | 2017 | 1711 | 0.100 |
Why?
| Area Under Curve | 3 | 2008 | 288 | 0.100 |
Why?
| Ventricular Function, Left | 1 | 2016 | 524 | 0.100 |
Why?
| Asthma | 1 | 2006 | 2212 | 0.100 |
Why?
| Models, Biological | 1 | 2019 | 1689 | 0.100 |
Why?
| Models, Theoretical | 1 | 2015 | 541 | 0.100 |
Why?
| Regression Analysis | 2 | 2025 | 978 | 0.100 |
Why?
| Fetal Growth Retardation | 1 | 2017 | 543 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1473 | 0.100 |
Why?
| Pyruvic Acid | 2 | 2010 | 52 | 0.100 |
Why?
| Physicians | 1 | 2020 | 858 | 0.090 |
Why?
| Emotions | 1 | 2017 | 535 | 0.090 |
Why?
| Linear Models | 2 | 2014 | 816 | 0.090 |
Why?
| Hypoglycemia | 1 | 2016 | 425 | 0.090 |
Why?
| Disease Progression | 2 | 2022 | 2598 | 0.090 |
Why?
| Creatinine | 3 | 2020 | 478 | 0.090 |
Why?
| Treatment Outcome | 6 | 2019 | 10110 | 0.090 |
Why?
| Hypertension | 1 | 2019 | 1234 | 0.090 |
Why?
| Internship and Residency | 1 | 2020 | 1043 | 0.080 |
Why?
| Jet Lag Syndrome | 1 | 2019 | 8 | 0.080 |
Why?
| Acyl Coenzyme A | 2 | 2006 | 30 | 0.080 |
Why?
| Protein Kinase C beta | 1 | 2008 | 21 | 0.080 |
Why?
| Palmitates | 1 | 2008 | 18 | 0.080 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 39 | 0.080 |
Why?
| Sensitivity and Specificity | 2 | 2025 | 1813 | 0.070 |
Why?
| Diabetes, Gestational | 1 | 2012 | 308 | 0.070 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 167 | 0.070 |
Why?
| Quality Improvement | 1 | 2016 | 1093 | 0.070 |
Why?
| Muscle Cells | 1 | 2007 | 39 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2005 | 488 | 0.070 |
Why?
| Acetates | 1 | 2007 | 96 | 0.070 |
Why?
| Albuminuria | 2 | 2020 | 181 | 0.070 |
Why?
| Longitudinal Studies | 2 | 2024 | 2706 | 0.070 |
Why?
| Trauma Severity Indices | 1 | 2007 | 104 | 0.070 |
Why?
| Alberta | 1 | 2006 | 14 | 0.060 |
Why?
| Islets of Langerhans | 1 | 2012 | 790 | 0.060 |
Why?
| Phenylalanine | 4 | 2009 | 65 | 0.060 |
Why?
| Muscular Atrophy | 1 | 2006 | 79 | 0.060 |
Why?
| Animals | 8 | 2017 | 34487 | 0.060 |
Why?
| Carbon Dioxide | 1 | 2007 | 258 | 0.060 |
Why?
| Milk | 1 | 2006 | 119 | 0.060 |
Why?
| Critical Care | 1 | 2010 | 550 | 0.060 |
Why?
| Caseins | 1 | 2004 | 18 | 0.060 |
Why?
| Self Report | 1 | 2019 | 796 | 0.060 |
Why?
| Oxidation-Reduction | 1 | 2008 | 1001 | 0.060 |
Why?
| Cystatin C | 2 | 2014 | 65 | 0.060 |
Why?
| Albumins | 1 | 2005 | 101 | 0.060 |
Why?
| Fibrinogen | 1 | 2005 | 158 | 0.060 |
Why?
| Physical Exertion | 1 | 2005 | 207 | 0.050 |
Why?
| Mitochondrial Diseases | 1 | 2024 | 88 | 0.050 |
Why?
| Placebos | 2 | 2019 | 201 | 0.050 |
Why?
| Stress, Physiological | 1 | 2006 | 411 | 0.050 |
Why?
| Dietary Carbohydrates | 1 | 2003 | 150 | 0.050 |
Why?
| Exercise Test | 3 | 2016 | 613 | 0.050 |
Why?
| Glycolysis | 1 | 2024 | 293 | 0.050 |
Why?
| Culture Media, Conditioned | 1 | 2022 | 108 | 0.050 |
Why?
| Light | 1 | 2025 | 353 | 0.050 |
Why?
| Ambulatory Care | 1 | 2006 | 500 | 0.050 |
Why?
| Critical Illness | 1 | 2007 | 755 | 0.050 |
Why?
| Gonadotropins | 1 | 2020 | 37 | 0.040 |
Why?
| Hydroxyestrones | 1 | 2000 | 2 | 0.040 |
Why?
| Pregnancy | 3 | 2020 | 6355 | 0.040 |
Why?
| Isoflavones | 1 | 2000 | 25 | 0.040 |
Why?
| Sex Chromosome Aberrations | 1 | 2020 | 63 | 0.040 |
Why?
| Chromosomes, Human, X | 1 | 2020 | 72 | 0.040 |
Why?
| Anti-Mullerian Hormone | 1 | 2020 | 53 | 0.040 |
Why?
| Salaries and Fringe Benefits | 1 | 2020 | 55 | 0.040 |
Why?
| Parental Leave | 1 | 2020 | 23 | 0.040 |
Why?
| Trisomy | 1 | 2020 | 77 | 0.040 |
Why?
| Causality | 1 | 2019 | 115 | 0.040 |
Why?
| Administration, Oral | 3 | 2006 | 766 | 0.040 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1482 | 0.040 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 46 | 0.040 |
Why?
| Hormones | 1 | 2019 | 140 | 0.040 |
Why?
| Rats, Zucker | 2 | 2010 | 30 | 0.040 |
Why?
| Biological Transport | 2 | 2010 | 396 | 0.030 |
Why?
| Diabetic Angiopathies | 1 | 2019 | 261 | 0.030 |
Why?
| Magnetic Resonance Angiography | 1 | 2018 | 235 | 0.030 |
Why?
| Whey Proteins | 2 | 2006 | 4 | 0.030 |
Why?
| Physicians, Primary Care | 1 | 2018 | 226 | 0.030 |
Why?
| Infant, Newborn | 2 | 2020 | 5688 | 0.030 |
Why?
| Tertiary Care Centers | 1 | 2016 | 146 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2016 | 108 | 0.030 |
Why?
| Sheep | 1 | 2017 | 828 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1537 | 0.030 |
Why?
| Oxidative Stress | 1 | 2021 | 1181 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2018 | 1408 | 0.030 |
Why?
| Infant | 2 | 2019 | 8912 | 0.030 |
Why?
| Rabbits | 2 | 2005 | 761 | 0.030 |
Why?
| Stress, Mechanical | 1 | 2016 | 460 | 0.030 |
Why?
| Mothers | 1 | 2020 | 729 | 0.030 |
Why?
| Weight Loss | 1 | 2018 | 725 | 0.030 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 141 | 0.030 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2014 | 197 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 2016 | 759 | 0.030 |
Why?
| Cholesterol, LDL | 1 | 2014 | 357 | 0.020 |
Why?
| Diet | 1 | 2000 | 1198 | 0.020 |
Why?
| Glucagon | 1 | 2012 | 105 | 0.020 |
Why?
| Parents | 1 | 2020 | 1303 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2014 | 1492 | 0.020 |
Why?
| Malonyl Coenzyme A | 1 | 2010 | 5 | 0.020 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2010 | 33 | 0.020 |
Why?
| Glycogen | 1 | 2010 | 55 | 0.020 |
Why?
| Adaptation, Physiological | 1 | 2014 | 513 | 0.020 |
Why?
| Rats | 2 | 2010 | 5199 | 0.020 |
Why?
| Sciatic Nerve | 1 | 2010 | 59 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2010 | 390 | 0.020 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 4 | 0.020 |
Why?
| Clinical Protocols | 1 | 2010 | 253 | 0.020 |
Why?
| Lactic Acid | 1 | 2010 | 294 | 0.020 |
Why?
| Primary Health Care | 1 | 2018 | 1639 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2010 | 755 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 815 | 0.020 |
Why?
| Radioactive Tracers | 1 | 2007 | 3 | 0.020 |
Why?
| Citric Acid Cycle | 1 | 2007 | 50 | 0.020 |
Why?
| Sodium Bicarbonate | 1 | 2007 | 37 | 0.020 |
Why?
| Breath Tests | 1 | 2007 | 89 | 0.020 |
Why?
| Cholesterol | 1 | 2008 | 406 | 0.020 |
Why?
| Multienzyme Complexes | 1 | 2006 | 68 | 0.020 |
Why?
| Diglycerides | 1 | 2006 | 61 | 0.020 |
Why?
| Palmitoylcarnitine | 1 | 2005 | 1 | 0.020 |
Why?
| Methods | 1 | 2005 | 64 | 0.020 |
Why?
| Carbohydrate Sequence | 1 | 2005 | 24 | 0.020 |
Why?
| Palmitic Acid | 1 | 2005 | 40 | 0.020 |
Why?
| Reference Standards | 1 | 2005 | 168 | 0.020 |
Why?
| AMP-Activated Protein Kinases | 1 | 2006 | 189 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2006 | 311 | 0.010 |
Why?
| Metabolic Clearance Rate | 1 | 2005 | 108 | 0.010 |
Why?
| Weight Lifting | 1 | 2004 | 34 | 0.010 |
Why?
| Dietary Supplements | 1 | 2008 | 531 | 0.010 |
Why?
| Hydrocortisone | 1 | 2006 | 304 | 0.010 |
Why?
| Leucine | 1 | 2004 | 108 | 0.010 |
Why?
| Patient Discharge | 1 | 2010 | 850 | 0.010 |
Why?
| Fluorocarbons | 1 | 2005 | 109 | 0.010 |
Why?
| Phenotype | 1 | 2012 | 3039 | 0.010 |
Why?
| Chromatography, Liquid | 1 | 2005 | 377 | 0.010 |
Why?
| Heart Rate | 1 | 2007 | 797 | 0.010 |
Why?
| Analysis of Variance | 1 | 2006 | 1266 | 0.010 |
Why?
| Blood Proteins | 1 | 2005 | 239 | 0.010 |
Why?
| Phosphorylation | 1 | 2006 | 1681 | 0.010 |
Why?
| Motor Activity | 1 | 2006 | 667 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2005 | 2042 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2005 | 2820 | 0.010 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2000 | 38 | 0.010 |
Why?
| Premenopause | 1 | 2000 | 121 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2005 | 2508 | 0.010 |
Why?
| Signal Transduction | 1 | 2006 | 4812 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2000 | 2131 | 0.000 |
Why?
|
|
Cree's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|